Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg SR is a triple-action oral antidiabetic medication designed to manage type 2 diabetes mellitus effectively. Glimepiride stimulates the pancreas to produce more insulin, helping reduce blood glucose levels. Pioglitazone improves insulin sensitivity in muscle and fat tissues, allowing better glucose uptake. Metformin (Sustained Release) decreases hepatic glucose production and improves insulin sensitivity, ensuring steady blood sugar control throughout the day. This combination provides comprehensive glycemic control by targeting multiple mechanisms of diabetes simultaneously. The SR formulation ensures extended release, reducing dosing frequency and minimizing gastrointestinal side effects compared to regular metformin. Ideal for patients who need enhanced blood sugar regulation, this therapy supports long-term diabetes management, improves insulin action, and helps prevent diabetes-related complications.
